Your search returned 25 results.

Results
	1.	Long-term safety and effectiveness of ritonavir, nelfinavir, and lopinavir/ritonavir in antiretroviral-experienced HIV-infected children. [electronic resource] by Rudin, Christoph Burri, Marcus Shen, Yang Rode, Richard Nadal, David Producer: 20080626 In: The Pediatric infectious disease journal vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Occurrence of selective ritonavir nonadherence and dose-staggering in recipients of boosted HIV-1 protease inhibitor therapy. [electronic resource] by Shuter, Jonathan Sarlo, Julie A Rode, Richard A Zingman, Barry S Producer: 20091015 In: HIV clinical trials vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Successful projection of the time course of drug concentration in plasma during a 1-year period from electronically compiled dosing-time data used as input to individually parameterized pharmacokinetic models. [electronic resource] by Vrijens, Bernard Tousset, Eric Rode, Richard Bertz, Richard Mayer, Steve Urquhart, John Producer: 20050729 In: Journal of clinical pharmacology vol. 45 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Modelling the association between adherence and viral load in HIV-infected patients. [electronic resource] by Vrijens, Bernard Goetghebeur, Els de Klerk, Erik Rode, Richard Mayer, Steve Urquhart, John Producer: 20051213 In: Statistics in medicine vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	HIV-infected patients receiving lopinavir/ritonavir-based antiretroviral therapy achieve high rates of virologic suppression despite adherence rates less than 95%. [electronic resource] by Shuter, Jonathan Sarlo, Julie A Kanmaz, Tina J Rode, Richard A Zingman, Barry S Producer: 20070612 In: Journal of acquired immune deficiency syndromes (1999) vol. 45 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Sequential antiretroviral adherence measurement using electronic bottle cap monitors in a cohort of HIV-infected adults. [electronic resource] by Shuter, Jonathan Sarlo, Julie A Stubbs, Roxann O Rode, Richard A Zingman, Barry S Producer: 20140204 In: Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Decreased adherence to antiretroviral therapy observed prior to transient human immunodeficiency virus type 1 viremia. [electronic resource] by Podsadecki, Thomas J Vrijens, Bernard C Tousset, Eric P Rode, Richard A Hanna, George J Producer: 20080219 In: The Journal of infectious diseases vol. 196 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	"White coat compliance" limits the reliability of therapeutic drug monitoring in HIV-1-infected patients. [electronic resource] by Podsadecki, Thomas J Vrijens, Bernard C Tousset, Eric P Rode, Richard A Hanna, George J Producer: 20081007 In: HIV clinical trials vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Lopinavir/ritonavir in pregnancy. [electronic resource] by Roberts, Susan S Martinez, Marisol Covington, Deborah L Rode, Richard A Pasley, Mary V Woodward, William C Producer: 20090811 In: Journal of acquired immune deficiency syndromes (1999) vol. 51 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Predictive genotypic algorithm for virologic response to lopinavir-ritonavir in protease inhibitor-experienced patients. [electronic resource] by King, Martin S Rode, Richard Cohen-Codar, Isabelle Calvez, Vincent Marcelin, Anne-Geneviève Hanna, George J Kempf, Dale J Producer: 20080108 In: Antimicrobial agents and chemotherapy vol. 51 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Successful treatment with atazanavir and lopinavir/ritonavir combination therapy in protease inhibitor-susceptible and protease inhibitor-resistant HIV-infected patients. [electronic resource] by Gilliam, Bruce L Chan-Tack, Kirk M Qaqish, Roula B Rode, Richard A Fantry, Lori E Redfield, Robert R Producer: 20070206 In: AIDS patient care and STDs vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Analysis of the virological response with respect to baseline viral phenotype and genotype in protease inhibitor-experienced HIV-1-infected patients receiving lopinavir/ritonavir therapy. [electronic resource] by Kempf, Dale J Isaacson, Jeffrey D King, Martin S Brun, Scott C Sylte, Jacquelyn Richards, Bruce Bernstein, Barry Rode, Richard Sun, Eugene Producer: 20040109 In: Antiviral therapy vol. 7 Availability: No items available. Save to lists Add to cart (remove)
	13.	Virologic response to lopinavir-ritonavir-based antiretroviral regimens in a multicenter international clinical cohort: comparison of genotypic interpretation scores. [electronic resource] by Grant, Philip Wong, Eric C Rode, Richard Shafer, Robert De Luca, Andrea Nadler, Jeffrey Hawkins, Trevor Cohen, Calvin Harrington, Robert Kempf, Dale Zolopa, Andrew Producer: 20090121 In: Antimicrobial agents and chemotherapy vol. 52 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	Virtual inhibitory quotient predicts response to ritonavir boosting of indinavir-based therapy in human immunodeficiency virus-infected patients with ongoing viremia. [electronic resource] by Shulman, Nancy Zolopa, Andrew Havlir, Diane Hsu, Ann Renz, Cheryl Boller, Sheila Jiang, Ping Rode, Richard Gallant, Joel Race, Elizabeth Kempf, Dale J Sun, Eugene Producer: 20030501 In: Antimicrobial agents and chemotherapy vol. 46 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	A lopinavir/ritonavir-based once-daily regimen results in better compliance and is non-inferior to a twice-daily regimen through 96 weeks. [electronic resource] by Molina, Jean-Michel Podsadecki, Thomas J Johnson, Margaret A Wilkin, Aimee Domingo, Pere Myers, Robert Hairrell, Jan M Rode, Richard A King, Martin S Hanna, George J Producer: 20080304 In: AIDS research and human retroviruses vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16.	The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in period. [electronic resource] by Weeke, Peter Andersson, Charlotte Fosbøl, Emil L Brendorp, Bente Køber, Lars Sharma, Arya M Finer, Nick James, Philip T Caterson, Ian D Rode, Richard A Torp-Pedersen, Christian Producer: 20110714 In: BMC endocrine disorders vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	17.	Differential changes in serum uric acid concentrations in sibutramine promoted weight loss in diabetes: results from four weeks of the lead-in period of the SCOUT trial. [electronic resource] by Andersson, Charlotte Weeke, Peter Brendorp, Bente Køber, Lars Fosbøl, Emil L Sharma, Arya M Finer, Nick Caterson, Ian D Rode, Richard A James, Philip T Torp-Pedersen, Christian Producer: 20121002 In: Nutrition & metabolism vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	18.	Pharmacokinetic-pharmacodynamic analysis of lopinavir-ritonavir in combination with efavirenz and two nucleoside reverse transcriptase inhibitors in extensively pretreated human immunodeficiency virus-infected patients. [electronic resource] by Hsu, Ann Isaacson, Jeffrey Brun, Scott Bernstein, Barry Lam, Wayne Bertz, Richard Foit, Cheryl Rynkiewicz, Karen Richards, Bruce King, Martin Rode, Richard Kempf, Dale J Granneman, G Richard Sun, Eugene Producer: 20030603 In: Antimicrobial agents and chemotherapy vol. 47 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	19.	Fat tissue distribution changes in HIV-infected patients treated with lopinavir/ritonavir. Results of the MONARK trial. [electronic resource] by Kolta, Sami Flandre, Philippe Van, Philippe Ngo Cohen-Codar, Isabelle Valantin, Marc-Antoine Pintado, Claire Morlat, Philippe Boué, Francois Rode, Richard Norton, Michael Knysz, Brygida Briot, Karine Roux, Christian Delfraissy, Jean-François Producer: 20110502 In: Current HIV research vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	20.	Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. [electronic resource] by James, W Philip T Caterson, Ian D Coutinho, Walmir Finer, Nick Van Gaal, Luc F Maggioni, Aldo P Torp-Pedersen, Christian Sharma, Arya M Shepherd, Gillian M Rode, Richard A Renz, Cheryl L Producer: 20100916 In: The New England journal of medicine vol. 363 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search

Availability

Authors

Topics

Languages

Your search returned 25 results.